venous-thromboembolism

Documents about venous-thromboembolism

• Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.#864698ClinicalTrials.gov
• Characterization of Thrombin Generation Curve Shape in Presence of Platelets from Acute Venous Thromboembolism Patients#239122HAL (France)
• SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty#829847ClinicalTrials.gov
• Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer#843519ClinicalTrials.gov
• Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort#852642ClinicalTrials.gov
• Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity#628614ClinicalTrials.gov
• Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study#834731ClinicalTrials.gov
• A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty#966961ClinicalTrials.gov
• Relationship between major depressive disorder and venous thromboembolism: a five-ancestry genetic analysis.#219406PubMed
• Xarelto Regulatory Post-Marketing Surveillance#802515ClinicalTrials.gov
• The Effect of Sock Developed with Wearable Technology for TUR Surgery Patients on Hypothermia and Venous Thromboembolism#838399ClinicalTrials.gov
• Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners#848402ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants#995372ClinicalTrials.gov
• Anticoagulation for Venous Thromboembolism: Impact on the Risk of Major Adverse Cardiovascular Events#1000756HAL (France)
• Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism#900261ClinicalTrials.gov
• VTE Prophylaxis Guidelines in Hospitalized Elders#882655ClinicalTrials.gov
• Microsurgical Breast Reconstruction & VTE#994656ClinicalTrials.gov
• A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty#849079ClinicalTrials.gov
• Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism#854519ClinicalTrials.gov
• Prophylaxis of Venous Thromboembolism After Bariatric Surgery#854366ClinicalTrials.gov
• Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database#971236HAL (France)
• The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study#807802ClinicalTrials.gov
• Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement#861534ClinicalTrials.gov
• Venous Thrombosis Virtual Surveillance in COVID-19#867956ClinicalTrials.gov
• Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients#917217ClinicalTrials.gov
• Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)#471552ClinicalTrials.gov
• A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US#846619ClinicalTrials.gov
• The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity#123577ClinicalTrials.gov
• Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism#866692ClinicalTrials.gov
• Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement#914558ClinicalTrials.gov
• Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study#918506ClinicalTrials.gov
• High-Risk Factors for VTE Death#829715ClinicalTrials.gov
• Thromboembolic Complications in Mild Covid-19 Cases#859792ClinicalTrials.gov
• Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)#860254ClinicalTrials.gov
• Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study#979126ClinicalTrials.gov
• Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism#874618ClinicalTrials.gov
• Safety and Tolerability of Dabigatran Etexilate in Adolescents#869938ClinicalTrials.gov
• Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients#967991ClinicalTrials.gov
• Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage#979400ClinicalTrials.gov
• A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer#897080ClinicalTrials.gov
• Ongoing Registry of Treatment of Venous Thromboembolism#855362ClinicalTrials.gov
• Education Bundle to Decrease Patient Refusal of VTE Prophylaxis#912172ClinicalTrials.gov
• The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients#852192ClinicalTrials.gov
• Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk#858046ClinicalTrials.gov
• Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)#980257ClinicalTrials.gov
• Optimal Duration of Anticoagulation in Deep Venous Thrombosis#865929ClinicalTrials.gov
• Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses#872425ClinicalTrials.gov
• Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates#807553ClinicalTrials.gov
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin#846986ClinicalTrials.gov
• Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients#442091ClinicalTrials.gov